Analytical and preanalytical biases in serum proteomic pattern analysis for breast cancer diagnosis

Clinical Chemistry

Volumn 51, Issue 8, 2005, Pages 1525-1528

  Karsan, Aly ^a,d   Eigl, Bernhard J ^a   Flibotte, Stephane ^a   Gelmon, Karen ^a   Switzer, Philip ^b   Hassell, Patricia ^a   Harrison, Dorothy ^a   Law, Jennifer ^a   Hayes, Malcolm ^a   Stillwell, Moira ^b   Xiao, Zhen ^c   Conrads, Thomas P ^c   Veenstra, Timothy ^c  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c SAIC FREDERICK INC   (United States)

^d BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMA PROTEIN;

ALGORITHM; ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; BREAST BIOPSY; BREAST CANCER; CANCER DIAGNOSIS; FEMALE; HUMAN; INTRADUCTAL CARCINOMA; LABORATORY TEST; MAJOR CLINICAL STUDY; PREDICTION; PROBABILITY; PROTEIN BLOOD LEVEL; PROTEOMICS; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

ALGORITHMS; BREAST NEOPLASMS; DIAGNOSIS, COMPUTER-ASSISTED; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; PROSPECTIVE STUDIES; PROTEIN ARRAY ANALYSIS; PROTEOME; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 23044465780     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.050708     Document Type: Article

References (17)

1. Diamandis EP. Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations. Mol Cell Proteomics 2004;3:367-78.
2. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002;359:572-7.
3. Sorace JM, Zhan M. A data review and re-assessment of ovarian cancer serum proteomic profiling. BMC Bioinformatics 2003;4:24.
4. Baggerly KA, Morris JS, Coombes KR. Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments. Bioinformatics 2004;20:777-85.
5. Diamandis EP. Point: Proteomic patterns in biological fluids: do they represent the future of cancer diagnostics? Clin Chem 2003;49:1272-5.
6. Diamandis EP. Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems. J Natl Cancer Inst 2004;96:353-6.
7. Zhang Z, Bast RC Jr, Yu Y, Li J, Sokoll LJ, Rai AJ, et al. Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res 2004;64:5882-90.
8. Witten IH, Frank E. Data mining: practical machine learning tools and techniques with JAVA implementations. San Francisco: Morgan Kaufman, 2000:371pp.
9. Pusztai L, Gregory BW, Baggerly KA, Peng B, Koomen J, Kuerer HM, et al. Pharmacoproteomic analysis of prechemotherapy and postchemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast carcinoma. Cancer 2004;100:1814-22.
10. Li J, Zhang Z, Rosenzweig J, Wang YY, Chan DW. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem 2002;48:1296-304.
11. Diamandis EP, van der Merwe DE. Plasma protein profiling by mass spectrometry for cancer diagnosis: opportunities and limitations. Clin Cancer Res 2005;11:963-5.
12. Coombes KR, Morris JS, Hu J, Edmonson SR, Baggerly KA. Serum proteomics profiling-a young technology begins to mature. Nat Biotechnol 2005;23: 291-2.
13. Semmes OJ, Feng Z, Adam BL, Banez LL, Bigbee WL, Campos D, et al. Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility. Clin Chem 2005;51:102-12.
14. Hortin GL. Can mass spectrometric protein profiling meet desired standards of clinical laboratory practice? Clin Chem 2005;51:3-5.
15. Ransohoff DF. Lessons from controversy: ovarian cancer screening and serum proteomics. J Natl Cancer Inst 2005;97:315-9.
16. Baggerly KA, Morris JS, Edmonson SR, Coombes KR. Signal in noise: evaluating reported reproducibility of serum proteomic tests for ovarian cancer. J Natl Cancer Inst 2005;97:307-9.
17. Liotta LA, Lowenthal M, Mehta A, Conrads TP, Veenstra TD, Fishman DA, et al. Importance of communication between producers and consumers of publicly available experimental data. J Natl Cancer Inst 2005;97:310-4.